Dhuwit awis saben lembar saham Universe Pharma (UPC)

Universe Pharmaceuticals - logo grafis emiten UPC

Universe Pharmaceuticals relies on qualified specialists in Eastern medicine while developing internal staff training. Production is based on a combination of proprietary extraction facilities and the engagement of external agricultural suppliers and logistics providers. The implementation of AI control and robotics in raw material processing optimizes operations. Cash per share demonstrates financial stability, where the current parameter equals 5.73.

Universe Pharmaceuticals INC (UPC) - Dhuwit awis saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Universe Pharmaceuticals

- rega saham lan prakiraan rega para ahli:
- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:UPC, Universe Pharmacy
Barang unggulan Universe Pharmaceuticals INC

Universe Pharmaceuticals controls indispensable supply chains in China, yet faces severe regulatory pressure on margins. This amount of cash per share demonstrates the remaining liquidity per unit of capital after deducting all liabilities. The metric defines a financial safety cushion that eliminates default risk during recessionary periods. The stability of this indicator confirms business resilience during low-income phases. Excess capital here guarantees survival but limits growth potential.